Integrated Filing — IndAS



General information about company

Scrip Code 523642
NSE Symbol PIIND
MSEI Symbol NOTLISTED
ISIN INE603J01030
Name of company PI INDUSTRIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 04-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 27-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Agri
Start date and time of board meeting 04-11-2026   14:00:00
End date and time of board meeting 04-11-2026   19:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 19-05-2026
Indicate Company website link for updated RPT policy of the Company https://www.piindustries.com/sustainability/policies/#governance-and-ethics
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No Default



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 1,53,350.00 3,13,240.00
Other income 6,250.00 12,330.00
Total income 1,59,600.00 3,25,570.00
2 Expenses
(a) Cost of materials consumed 75,970.00 1,38,820.00
(b) Purchases of stock-in-trade 3,750.00 6,700.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (1,200.00) 3,200.00
(d) Employee benefit expense 16,950.00 34,490.00
(e) Finance costs 190.00 420.00
(f) Depreciation, depletion and amortisation expense 8,220.00 16,250.00
(f) Other Expenses
1 Net Impairement Losses on Financial Assets 340.00 700.00
2 Power, fuel & water 8,540.00 15,960.00
3 Repairs & maintenance 2,940.00 5,420.00
4 Environment & pollution control expenses 2,840.00 5,480.00
5 Laboratory & testing charges 700.00 1,710.00
6 Freight & forwarding expense 1,970.00 3,100.00
7 Advertisement & sales promotion 1,750.00 3,360.00
8 Travelling and conveyance 1,830.00 3,890.00
9 Legal & professional fees 1,550.00 3,150.00
10 Other Expenses 5,740.00 11,700.00
Total other expenses 28,200.00 54,470.00
Total expenses 1,32,080.00 2,54,350.00
3 Total profit before exceptional items and tax 27,520.00 71,220.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 27,520.00 71,220.00
6 Tax expense
7 Current tax 4,520.00 11,710.00
8 Deferred tax 2,290.00 4,650.00
9 Total tax expenses 6,810.00 16,360.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 20,710.00 54,860.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 20,710.00 54,860.00
17 Other comprehensive income net of taxes 540.00 4,350.00
18 Total Comprehensive Income for the period 21,250.00 59,210.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,520.00 1,520.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 13.66 36.16
Diluted earnings (loss) per share from continuing operations 13.66 36.16
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 13.66 36.16
Diluted earnings (loss) per share from continuing and discontinued operations 13.66 36.16
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above standalone unaudited financial results were reviewed and recommended by the Audit Committee of the Company and approved by the Board of Directors at their meeting held on November 04, 2026. 2. The financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. 3. The Company is in the business of manufacturing and distribution of Agro Chemicals and accordingly has one reportable business segment viz. Agro Chemicals. 4.a) The carrying value of the Company equity investment in PI Health Sciences Limited (PIHS) had been reassessed as at March 31, 2026. There is no change in the underlying business strategy, however in view of the business losses and based on a valuation carried out by an independent valuer, the Company had recognised a provision of Rs 1,100 million in the year ended March 31, 2026. This was disclosed as an Exceptional Item in the financial results. The management remains confident about the long-term business prospects of PIHS. b) Pursuant to the notification of the New Labour Codes as issued in November 2025. The Company reassessed its employee benefit obligations in accordance with the revised definition of Wages and accordingly, an incremental liability of Rs 223 million was recognised as an Exceptional Item during the year ended March 31, 2026.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 3,20,290.00
Capital work-in-progress 84,230.00
Investment property
Goodwill 6,710.00
Other intangible assets 4,510.00
Intangible assets under development 28,370.00
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 2,32,570.00
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other Financial Assets 620.00
Total of other non-current financial assets 620.00
Total non-current financial assets 2,33,190.00
Deferred tax assets (net)
Other non-current assets
1 Current tax assets 450.00
2 Other non-current assets 9,220.00
Total of other non-current assets 9,670.00
Total non-current assets 6,86,970.00
2 Current assets
Inventories 1,03,570.00
Current financial asset
Current investments 1,92,820.00
Trade receivables, current 1,95,180.00
Cash and cash equivalents 25,230.00
Bank balance other than cash and cash equivalents 1,30,960.00
Loans, current 130.00
Other current financial assets
Total of other current financial assets 1,900.00
Total current financial assets 5,46,220.00
Current tax assets (net) 0.00
Other current assets
1 Other current assets 28,810.00
Total of other current assets 28,810.00
Total current assets 6,78,600.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 13,65,570.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,520.00
Other equity 11,79,410.00
Total equity attributable to owners of parent 11,80,930.00
Non controlling interest
Total equity 11,80,930.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease Liabilities 3,710.00
2 Other non-current financial liabilities 9,260.00
Total of other non-current financial liabilities 12,970.00
Total non-current financial liabilities 12,970.00
Provisions, non-current 1,070.00
Deferred tax liabilities (net) 8,380.00
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 22,420.00
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 7,050.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 94,040.00
Total Trade payable 1,01,090.00
Other current financial liabilities
1 Lease Liabilities 2,040.00
2 Other current financial liabilities 43,720.00
Total of other current financial liabilities 45,760.00
Total current financial liabilities 1,46,850.00
Other current liabilities 8,130.00
1 Other current liabilities 8,130.00
Total of other current liabilities 8,130.00
Provisions, current 3,540.00
Current tax liabilities (Net) 3,700.00
Deferred government grants, Current
Total current liabilities 1,62,220.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1,84,640.00
Total equity and liabilites 13,65,570.00
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) 1. The above standalone unaudited financial results were reviewed and recommended by the Audit Committee of the Company and approved by the Board of Directors at their meeting held on November 04, 2026. 2. The financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. 3. The Company is in the business of manufacturing and distribution of Agro Chemicals and accordingly has one reportable business segment viz. Agro Chemicals. 4.a) The carrying value of the Company equity investment in PI Health Sciences Limited (PIHS) had been reassessed as at March 31, 2026. There is no change in the underlying business strategy, however in view of the business losses and based on a valuation carried out by an independent valuer, the Company had recognised a provision of Rs 1,100 million in the year ended March 31, 2026. This was disclosed as an Exceptional Item in the financial results. The management remains confident about the long-term business prospects of PIHS. b) Pursuant to the notification of the New Labour Codes as issued in November 2025. The Company reassessed its employee benefit obligations in accordance with the revised definition of Wages and accordingly, an incremental liability of Rs 223 million was recognised as an Exceptional Item during the year ended March 31, 2026.



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurments gain/(loss) on defined benefits plan 150.00 290.00
Total Amount of items that will not be reclassified to profit and loss 150.00 290.00
2 Income tax relating to items that will not be reclassified to profit or loss 50.00 100.00
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gain/(loss) on cash flow hedges 670.00 6,390.00
Total Amount of items that will be reclassified to profit and loss 670.00 6,390.00
4 Income tax relating to items that will be reclassified to profit or loss 230.00 2,230.00
5 Total Other comprehensive income 540.00 4,350.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 71,220.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 420.00
Adjustments for decrease (increase) in inventories 1,450.00
Adjustments for decrease (increase) in trade receivables, current 6,980.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (10.00)
Adjustments for decrease (increase) in other non-current assets (540.00)
Adjustments for other financial assets, non-current (20.00)
Adjustments for other financial assets, current 2,130.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 15,110.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 1,130.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 16,250.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current (30.00)
Adjustments for other financial liabilities, current 6,000.00
Adjustments for other financial liabilities, non-current 150.00
Adjustments for unrealised foreign exchange losses gains 1,640.00
Adjustments for dividend income 0.00
Adjustments for interest income 7,620.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (3,650.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 90.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 1,050.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 40,530.00
Net cash flows from (used in) operations 1,11,750.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 8,460.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 1,03,290.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 33,550.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 470.00
Purchase of property, plant and equipment 58,700.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 7,620.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 1,690.00
Net cash flows from (used in) investing activities (82,470.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 1,090.00
Dividends paid 15,170.00
Interest paid 420.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (16,680.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 4,140.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents (490.00)
Net increase (decrease) in cash and cash equivalents 3,650.00
Cash and cash equivalents cash flow statement at beginning of period 21,580.00
Cash and cash equivalents cash flow statement at end of period 25,230.00





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 PI Industries Limited PI Life Science Research Limited Subsidiary Purchase of goods or services 1,100.00 - 374.30 (191.10) (178.10)
2 PI Industries Limited PI Life Science Research Limited Subsidiary Any other transaction Rent Income 16.00 - 7.40 0.00 0.00
3 PI Industries Limited PI Life Science Research Limited Subsidiary Any other transaction Recovery of Power Cost incurred 40.00 - 16.00 4.10 (0.90)
4 PI Industries Limited PI Health Sciences Limited Subsidiary Sale of goods or services 1,906.00 - 26.10 10.00 15.60
5 PI Industries Limited PI Health Sciences Limited Subsidiary Purchase of goods or services 400.00 - 277.00 0.00 (150.00)
6 PI Industries Limited PI Health Sciences Limited Subsidiary Any other transaction Rent Expense 400.00 - 228.30 (80.00) (41.10)
7 PI Industries Limited PI Health Sciences Limited Subsidiary Interest received 440.00 - 111.80 0.00 0.00
8 PI Industries Limited PI Health Sciences Limited Subsidiary Investment 12,000.00 - 12,000.00 88,000.00 0.00 Investment 0.500 10 Year (Redeemable after 5 Years), option to convert or redeem at a premium at any time after the expiry of 5 years from the date of allotment. Unsecured Working Capital and general corporate purpose Textual Information(1)
9 PI Industries Limited PI Health Sciences Limited Subsidiary Investment 9,500.00 - 7,200.00 0.00 0.00 Investment 0 NA Unsecured Working Capital and general corporate purpose
10 PI Industries Limited PI Health Sciences Limited Subsidiary Any other transaction Conversion of OFCD into equity shares 1,00,000.00 - 1,00,000.00 0.00 0.00 Textual Information(2)
11 PI Industries Limited PI Health Sciences Limited Subsidiary Any other transaction Reimbursement of Expenses 100.00 - 77.00 0.00 0.00
12 PI Industries Limited PI Health Sciences Limited Subsidiary Any other transaction Recovery of expense 200.00 - 0.00 0.00 0.00
13 PI Industries Limited Jivagro Limited Subsidiary Sale of goods or services 15,385.00 - 5,920.80 981.20 3,604.30
14 PI Industries Limited Jivagro Limited Subsidiary Purchase of goods or services 2,000.00 - 573.00 0.00 (169.20)
15 PI Industries Limited Jivagro Limited Subsidiary Any other transaction Rent Income 40.00 - 18.10 0.00 0.00
16 PI Industries Limited Jivagro Limited Subsidiary Any other transaction Recovery of Insurance premium 40.00 - 21.90 0.00 0.00
17 PI Industries Limited PI Innoventures Limited Subsidiary Any other transaction Management Services 1.00 - 0.30 0.20 0.40
18 PI Industries Limited PI Innoventures Limited Subsidiary Any other transaction Rent Expense 17.00 - 7.80 (2.20) (2.40)
19 PI Industries Limited PI Kumiai Private Limited Joint Venture of Subsidiary Purchase of goods or services 12,000.00 - 7,829.10 (1,432.80) (4,974.50)
20 PI Industries Limited PI Kumiai Private Limited Joint Venture of Subsidiary Sale of goods or services 13,000.00 - 7,500.00 178.60 5,051.30
21 PI Industries Limited PI Kumiai Private Limited Joint Venture of Subsidiary Any other transaction Rent Income 54.00 - 26.10 1,801.70 0.00
22 PI Industries Limited PI Kumiai Private Limited Joint Venture of Subsidiary Any other transaction Job Work Income 2,500.00 - 623.70 0.00 0.00
23 PI Industries Limited PI Kumiai Private Limited Joint Venture of Subsidiary Any other transaction Management services 107.00 - 51.40 0.00 0.00
24 PI Industries Limited Solinnos Agro Sciences Private Limited Associate of Subsidiary Sale of goods or services 15.00 - 5.50 0.00 3.20
25 PI Industries Limited PI Industries Management Consultancies LLC Subsidiary Purchase of goods or services 1,500.00 - 1,121.00 (255.50) (904.60)
26 PI Industries Limited PI Industries Management Consultancies LLC Subsidiary Investment 23,000.00 - 14,351.80 0.00 0.00
27 PI Industries Limited PI Japan Co. Ltd Subsidiary Purchase of goods or services 650.00 - 483.50 (110.70) (116.90)
28 PI Industries Limited PI Foundation Entity controlled by KMP and/or their relatives Any other transaction Contribution towards CSR Activities 3,800.00 - 1,993.80 0.00 0.00
29 PI Industries Limited PII ESOP Trust Controlled Trust Loan 70.00 - 0.00 70.00 70.00 Loan 0 NA Unsecured ESOP Textual Information(3)
30 PI Industries Limited Shri Salil Singhal Relative of KMP Remuneration 144.00 - 72.20 0.00 (40.80)
31 PI Industries Limited Shri Salil Singhal Relative of KMP Any other transaction Travel & reimbursement of other expenses Approved At Actual 20.30 0.00 0.00
32 PI Industries Limited Mrs Madhu Singhal Relative of KMP Any other transaction Rent Expense 25.00 - 11.00 0.00 0.00
33 PI Industries Limited Ms. Pooja Singhal Relative of KMP Any other transaction Rent Expense 4.00 - 1.50 0.00 0.00
34 PI Industries Limited Mr. Mayank Singhal Key Managerial Personnel Remuneration 1,218.00 - 609.00 0.00 0.00
35 PI Industries Limited Mr. Mayank Singhal Key Managerial Personnel Any other transaction Commission 1,500.00 - 1,500.00 (1,500.00) 0.00
36 PI Industries Limited Mr. Vinayak Singhal Relative of KMP Remuneration 90.00 - 38.60 0.00 0.00
37 PI Industries Limited Pure Home & Living Private Limited Entity controlled by KMP and/or their relatives Purchase of goods or services 10.00 - 0.50 0.00 0.00
38 PI Industries Limited Wolkem India Limited Entity controlled by KMP and/or their relatives Purchase of goods or services 20.00 - 4.10 0.00 0.00
39 Jivagro Limited PI Foundation Other Related Party Any other transaction Contribution towards CSR Activities Exempted 30.00 0.00 0.00
40 PI Industries Management Consultancies LLC PI AgSciences Limited (Formerly Plant Health Care Plc) Subsidiary Investment Exempted 14,367.30 0.00 0.00 Investment 0 NA Unsecured Working Capital and general corporate purpose Textual Information(4)
41 PI Life Science Research Limited PI Foundation Other Related Party Any other transaction Contribution towards CSR Activities Exempted 7.30 0.00 0.00
42 PI Life Science Research Limited Solinnos Agro Sciences Private Limited Associate Purchase of goods or services 25.80 - 4.90 0.00 (2.30)
43 PI Life Science Research Limited PI Flowtech B.V. Subsidiary Any other transaction Recovery of expenses incurred Exempted 3.20 22.00 24.80
44 PI Life Science Research Limited PI Health Sciences Limited Fellow Subsidiary Any other transaction Recovery of expenses incurred Exempted 1.30 0.00 1.30
45 PI Health Sciences Limited PI Health Sciences Netherlands B.V Subsidiary Any other transaction Receipt of Interest Due Exempted 6.30 6.30 0.00
46 PI Health Sciences Limited Archimica S.p.A Step Down Subsidiary Any other transaction Business Support Services provided Exempted 36.80 (18.60) 0.00
47 PI Health Sciences Limited Archimica S.p.A Step Down Subsidiary Any other transaction Business Support Services provided Exempted 102.90 0.00 102.90
48 PI Health Sciences Limited Archimica S.p.A Step Down Subsidiary Sale of goods or services Exempted 3.60 0.00 0.00
49 PI Health Sciences Limited PI Health Sciences USA, LLC Step Down Subsidiary Any other transaction Business Support Services received Exempted 974.90 (1,378.50) (1,177.80)
50 PI Health Sciences Limited PI AgSciences Limited Fellow Subsidiary Sale of goods or services Exempted 3.30 3.30 0.00
51 PI Health Sciences Netherlands B.V Archimica S.p.A Subsidiary Investment Exempted 11,169.30 0.00 0.00 Investment 0 NA Unsecured Working Capital and general corporate expenses
52 Archimica S.p.A PI Health Sciences USA, LLC Fellow Subsidiary Any other transaction Business Support Services received Exempted 20.60 (54.90) 20.60
53 PI Industries Management Consultancies LLC PI AgSciences Brasil Ltda Fellow Subsidiary Purchase of goods or services Exempted 389.90 0.00 (389.90)
Total value of transaction during the reporting period 1,90,224.50



Text Block

Textual Information(1) Investment in Optionally fully convertible debentures
Textual Information(2) Conversion of outstanding OFCD of Rs 8800 from March 2026 and further OFCD issuance during H1 2026,totalling to Rs 10000 Mn
Textual Information(3) Interest Free Loan
Textual Information(4) Investment in 1,16,74,41,741 Equity Shares of GBP 0.01 each